Novartis Oncology Financial Analyst Salaries in Wilmington, DE
The average Novartis Oncology Financial Analyst in Wilmington, DE earns an estimated $72,543 annually, which includes an estimated base salary of $67,943 with a $4,600 bonus. Novartis Oncology's Financial Analyst compensation is $14,857 less than the US average for a Financial Analyst. Financial Analyst salaries at Novartis Oncology in Wilmington, DE can range from $66,000 - $75,000.
In Wilmington, DE, The Finance Department at Novartis Oncology earns $16,348 more on average than the Admin Department.
Last updated 3 years ago.
- $67,943
- avg. base
- $4,600
- avg. bonus
Financial Analyst Salaries at Novartis Oncology
In Wilmington, DE, Financial Analysts earn $1,535 more than Financial Analysts, and $17,737 less than Senior Accountants.
Compensation at Novartis Oncology by Department
In Wilmington, DE, The Finance Department averages $16,348 more than the Admin Department, and $12,531 less than the IT Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to Novartis Oncology reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to Novartis Oncology reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
How Financial Analysts at Novartis Oncology Rate Their Compensation
The majority of Financial Analysts at Novartis Oncology believe they're not compensated fairly. 100% of Financial Analysts at Novartis Oncology say they receive annual bonuses, and the vast majority (83%) are satisfied with their benefits. See more compensation ratings at Novartis Oncology
